Delivery Order SPE2DB22D3501-SPE2DB24FWU83

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,083.96, is for the delivery of 4565910632 - Cefazolin 2 G/50 ML-Dextroses, a critical medical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,561,504,751 units of Cefazolin 2 g/50 mL-Dextrose. The $4,749.84 firm fixed-price contract has a completion date of July 17, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,303.16 Firm Fixed Price delivery order is for the supply of Cefazolin 2 G/50 ML-Dextrose, a critical antibiotic medication. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,211.80 firm fixed-price delivery order, awarded on August 26, 2024, is for the supply of 4,565,586,219 units of cefazolin 1 g/50 ml-dextrose solution. The contract has an ultimate completion date of August 27, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,218.68 for the supply of 4,566,770,365 units of the drug Cefazolin 2 G/50 ML-Dextroses. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of December 20, 2024. No set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.52 firm-fixed-price delivery order is for the supply of CEFAZOLIN 1 G/50 ML-DEXTROSES, a medical product, with an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of Cefazolin 2 g/50 ml-dextrose medical supplies to the Defense Logistics Agency (DLA). The award, valued at $1,228.56, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of February 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.56 firm fixed-price delivery order is for the supply of 4567644031 CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product. The contract has an ultimate completion date of March 21, 2025 and was awarded on March 20, 2025. It is not associated with a set-aside program. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,548.84 firm-fixed price delivery order is for the supply of Cefazolin 2 G/50 ML-Dextrose, a critical pharmaceutical product. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,187.46, is for the delivery of Cefazolin 2 G/50 ML-Dextroses, a type of antibiotic medication. The contract has a firm fixed price pricing type and a completion date of November 22, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWU83
    Delivery Order

This federal contract award is a delivery order worth $4,335.84 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor. The order is for the supply of 4565633467 Cefazolin 2 g/50 mL-Dextroses, a critical care medical product. The contract has a firm-fixed price pricing type and a period of performance through August 30, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This delivery order is not associated with any set-aside designation.

Generated 11/28/24, 9:09 AM